Monday, May 20, 2013 5:51pm EDT
REGN - Regeneron Pharmaceuticals Inc - Insider Transactions
SEC Form 4 |
Date |
Sym |
Company |
Insider |
Title |
Shares |
Transaction |
Value |
|---|---|---|---|---|---|---|---|---|
MMay 15 2013 | REGN | Regeneron Pharmaceuticals Inc | Brown Michael S | Director | 15,000 | Option exercise at $24.41 | $366,150 | |
MMay 15 2013 | REGN | Regeneron Pharmaceuticals Inc | Brown Michael S | Director | 15,000 | Sale at $275.19 | $4,127,920 | |
May 13 2013 | REGN | Regeneron Pharmaceuticals Inc | Aberman Michael S | VP Strategy, Investor Relat | 12,500 | Option exercise at $24.00 | $300,000 | |
MMay 13 2013 | REGN | Regeneron Pharmaceuticals Inc | Aberman Michael S | VP Strategy, Investor Relat | 6,971 | Option payment at $275.97 | $1,923,787 | |
MMay 14 2013 | REGN | Regeneron Pharmaceuticals Inc | Aberman Michael S | VP Strategy, Investor Relat | 5,529 | Sale at $279.61 | $1,545,960 | |
May 10 2013 | REGN | Regeneron Pharmaceuticals Inc | Stahl Neil | SVP Research, Development S | 55,438 | Option exercise at $21.92 | $1,215,201 | |
MMay 10 2013 | REGN | Regeneron Pharmaceuticals Inc | Stahl Neil | SVP Research, Development S | 32,400 | Option payment at $268.40 | $8,696,160 | |
MMay 13 2013 | REGN | Regeneron Pharmaceuticals Inc | Stahl Neil | SVP Research, Development S | 23,038 | Sale at $276.88 | $6,378,806 | |
May 10 2013 | REGN | Regeneron Pharmaceuticals Inc | Sing George L | Director | 5,000 | Option exercise at $15.01 | $75,050 | |
May 10 2013 | REGN | Regeneron Pharmaceuticals Inc | Sing George L | Director | 5,000 | Sale at $270.00 | $1,350,000 | |
MMay 7 2013 | REGN | Regeneron Pharmaceuticals Inc | Terifay Robert J | SVP Commercial | 16,923 | Option exercise at $16.80 | $284,306 | |
MMay 7 2013 | REGN | Regeneron Pharmaceuticals Inc | Terifay Robert J | SVP Commercial | 8,692 | Option payment at $261.67 | $2,274,436 | |
MMay 8 2013 | REGN | Regeneron Pharmaceuticals Inc | Terifay Robert J | SVP Commercial | 8,231 | Sale at $261.23 | $2,150,192 | |
MMay 6 2013 | REGN | Regeneron Pharmaceuticals Inc | Aberman Michael S | VP Strategy, Investor Relat | 8,334 | Option exercise at $24.00 | $200,016 | |
MMay 6 2013 | REGN | Regeneron Pharmaceuticals Inc | Aberman Michael S | VP Strategy, Investor Relat | 8,334 | Sale at $257.13 | $2,142,927 | |
MMay 6 2013 | REGN | Regeneron Pharmaceuticals Inc | Gilman Alfred G | Director | 30,000 | Option exercise at $21.77 | $652,950 | |
MMay 6 2013 | REGN | Regeneron Pharmaceuticals Inc | Gilman Alfred G | Director | 30,000 | Sale at $261.04 | $7,831,302 | |
MMay 6 2013 | REGN | Regeneron Pharmaceuticals Inc | Shooter Eric M | Director | 20,000 | Option exercise at $37.09 | $741,800 | |
MMay 6 2013 | REGN | Regeneron Pharmaceuticals Inc | Shooter Eric M | Director | 30,000 | Sale at $260.23 | $7,806,872 | |
MMay 6 2013 | REGN | Regeneron Pharmaceuticals Inc | Shooter Eric M | Director | 10,000 | Converted deriv at $0.00 | $0 | |
MMay 6 2013 | REGN | Regeneron Pharmaceuticals Inc | Tessier-Lavigne Marc | Director | 13,334 | Option exercise at $53.23 | $709,834 | |
MMay 6 2013 | REGN | Regeneron Pharmaceuticals Inc | Tessier-Lavigne Marc | Director | 13,334 | Sale at $260.91 | $3,478,942 | |
MMay 6 2013 | REGN | Regeneron Pharmaceuticals Inc | Van Plew Daniel P | SVP, General Mgr Industrial O | 32,950 | Option exercise at $16.80 | $553,560 | |
MMay 6 2013 | REGN | Regeneron Pharmaceuticals Inc | Van Plew Daniel P | SVP, General Mgr Industrial O | 15,323 | Option payment at $260.44 | $3,990,722 | |
MMay 7 2013 | REGN | Regeneron Pharmaceuticals Inc | Van Plew Daniel P | SVP, General Mgr Industrial O | 13,725 | Sale at $261.61 | $3,590,637 | |
MJan 8 2013 | REGN | Regeneron Pharmaceuticals Inc | Vagelos P Roy | Chairman | 2,469 | Gift at $0.00 | $0 | |
MMay 6 2013 | REGN | Regeneron Pharmaceuticals Inc | Vagelos P Roy | Chairman | 13,482 | Sale at $263.21 | $3,548,550 | |
May 6 2013 | REGN | Regeneron Pharmaceuticals Inc | Yancopoulos George | President Regeneron Laboratori | 192,308 | Option exercise at $13.00 | $2,500,004 | |
MMay 6 2013 | REGN | Regeneron Pharmaceuticals Inc | Yancopoulos George | President Regeneron Laboratori | 103,243 | Option payment at $260.44 | $26,888,607 | |
MMay 7 2013 | REGN | Regeneron Pharmaceuticals Inc | Yancopoulos George | President Regeneron Laboratori | 100,000 | Sale at $262.64 | $26,263,581 | |
MMay 1 2013 | REGN | Regeneron Pharmaceuticals Inc | Schleifer Leonard S | President, CEO | 100,000 | Sale at $237.65 | $23,765,289 | |
May 1 2013 | REGN | Regeneron Pharmaceuticals Inc | McCorkle Douglas S | VP Controller, Asst Treasurer | 5,875 | Option exercise at $52.03 | $305,676 | |
MMay 1 2013 | REGN | Regeneron Pharmaceuticals Inc | McCorkle Douglas S | VP Controller, Asst Treasurer | 3,662 | Option payment at $233.53 | $855,187 | |
MMay 2 2013 | REGN | Regeneron Pharmaceuticals Inc | McCorkle Douglas S | VP Controller, Asst Treasurer | 2,213 | Sale at $244.79 | $541,725 | |
Apr 11 2013 | REGN | Regeneron Pharmaceuticals Inc | McCorkle Douglas S | VP Controller, Asst Treasur | 5,875 | Option exercise at $30.63 | $179,951 | |
MApr 11 2013 | REGN | Regeneron Pharmaceuticals Inc | McCorkle Douglas S | VP Controller, Asst Treasur | 2,746 | Option payment at $204.57 | $561,749 | |
MApr 12 2013 | REGN | Regeneron Pharmaceuticals Inc | McCorkle Douglas S | VP Controller, Asst Treasur | 3,129 | Sale at $211.00 | $660,235 | |
Apr 1 2013 | REGN | Regeneron Pharmaceuticals Inc | Goldstein Joseph L | Director | 5,000 | Option exercise at $24.41 | $122,050 | |
Apr 1 2013 | REGN | Regeneron Pharmaceuticals Inc | Goldstein Joseph L | Director | 5,000 | Sale at $180.00 | $900,000 | |
MMar 21 2013 | REGN | Regeneron Pharmaceuticals Inc | Brown Michael S | Director | 15,000 | Option exercise at $18.61 | $279,150 | |
MMar 21 2013 | REGN | Regeneron Pharmaceuticals Inc | Brown Michael S | Director | 15,000 | Sale at $173.27 | $2,599,022 | |
Mar 19 2013 | REGN | Regeneron Pharmaceuticals Inc | Schleifer Leonard S | President, CEO | 3,655 | Sale at $175.02 | $639,698 | |
Mar 13 2013 | REGN | Regeneron Pharmaceuticals Inc | Schleifer Leonard S | President, CEO | 4,662 | Sale at $175.01 | $815,897 | |
Dec 24 2012 | REGN | Regeneron Pharmaceuticals Inc | Schleifer Leonard S | President, CEO | 59,271 | Gift at $0.00 | $0 | |
MMar 5 2013 | REGN | Regeneron Pharmaceuticals Inc | Schleifer Leonard S | President, CEO | 91,683 | Sale at $175.33 | $16,075,050 | |
MFeb 26 2013 | REGN | Regeneron Pharmaceuticals Inc | Shooter Eric M | Director | 10,000 | Converted deriv at $0.00 | $0 | |
MFeb 26 2013 | REGN | Regeneron Pharmaceuticals Inc | Shooter Eric M | Director | 10,000 | Sale at $160.00 | $1,600,000 | |
MJan 16 2013 | REGN | Regeneron Pharmaceuticals Inc | Goldberg Murray A | SVP Finance, Admin CFO Trea | 7,878 | Sale at $172.16 | $1,356,272 | |
MJan 9 2013 | REGN | Regeneron Pharmaceuticals Inc | Powchik Peter | SVP Clin Devel, Reg Affairs | 5,752 | Option exercise at $17.38 | $99,980 | |
Jan 9 2013 | REGN | Regeneron Pharmaceuticals Inc | Goldstein Joseph L | Director | 5,000 | Option exercise at $57.11 | $285,550 | |
Jan 9 2013 | REGN | Regeneron Pharmaceuticals Inc | Goldstein Joseph L | Director | 5,000 | Sale at $185.00 | $925,000 | |
MJan 4 2013 | REGN | Regeneron Pharmaceuticals Inc | Goldstein Joseph L | Director | 5,000 | Option exercise at $33.42 | $167,100 | |
MJan 4 2013 | REGN | Regeneron Pharmaceuticals Inc | Goldstein Joseph L | Director | 5,000 | Sale at $180.82 | $904,127 | |
Jan 2 2013 | REGN | Regeneron Pharmaceuticals Inc | Powchik Peter | SVP Clin Devel, Reg Affairs | 30,000 | Option exercise at $21.25 | $637,500 | |
MJan 2 2013 | REGN | Regeneron Pharmaceuticals Inc | Powchik Peter | SVP Clin Devel, Reg Affairs | 16,414 | Option payment at $177.82 | $2,918,737 | |
MJan 3 2013 | REGN | Regeneron Pharmaceuticals Inc | Powchik Peter | SVP Clin Devel, Reg Affairs | 13,586 | Sale at $182.11 | $2,474,091 | |
MDec 17 2012 | REGN | Regeneron Pharmaceuticals Inc | Sing George L | Director | 20,000 | Gift at $0.00 | $0 | |
Dec 20 2012 | REGN | Regeneron Pharmaceuticals Inc | Van Plew Daniel P | SVP, Gen Mgr IOPS | 2,050 | Option exercise at $16.80 | $34,440 | |
MDec 19 2012 | REGN | Regeneron Pharmaceuticals Inc | Yancopoulos George | EVP CSO Pres Regen Res Labs | 50,846 | Option exercise at $13.77 | $699,978 | |
MDec 18 2012 | REGN | Regeneron Pharmaceuticals Inc | Powchik Peter | SVP Clin Devel, Reg Affairs | 38,248 | Option exercise at $31.61 | $1,209,090 | |
MDec 18 2012 | REGN | Regeneron Pharmaceuticals Inc | Powchik Peter | SVP Clin Devel, Reg Affairs | 21,269 | Option payment at $178.62 | $3,799,069 | |
MDec 19 2012 | REGN | Regeneron Pharmaceuticals Inc | Powchik Peter | SVP Clin Devel, Reg Affairs | 16,979 | Sale at $175.43 | $2,978,700 | |
MDec 18 2012 | REGN | Regeneron Pharmaceuticals Inc | McCorkle Douglas S | VP Controller, Asst Treasurer | 4,625 | Option exercise at $21.25 | $98,281 | |
MDec 18 2012 | REGN | Regeneron Pharmaceuticals Inc | McCorkle Douglas S | VP Controller, Asst Treasurer | 2,032 | Option payment at $178.62 | $362,956 | |
MDec 18 2012 | REGN | Regeneron Pharmaceuticals Inc | McCorkle Douglas S | VP Controller, Asst Treasurer | 2,593 | Sale at $176.47 | $457,591 | |
Dec 18 2012 | REGN | Regeneron Pharmaceuticals Inc | Aberman Michael S | VP Strategy, Investor Relat | 1,200 | Option exercise at $24.00 | $28,800 | |
Dec 18 2012 | REGN | Regeneron Pharmaceuticals Inc | Terifay Robert J | SVP Commercial | 5,952 | Option exercise at $16.80 | $99,994 | |
MNov 21 2012 | REGN | Regeneron Pharmaceuticals Inc | Goldberg Murray A | SVP Fin, Admin CFO Asst Secy | 43,000 | Gift at $0.00 | $0 | |
Dec 14 2012 | REGN | Regeneron Pharmaceuticals Inc | Goldberg Murray A | SVP Fin, Admin CFO Asst Secy | 4,607 | Option payment at $179.13 | $825,252 | |
Dec 17 2012 | REGN | Regeneron Pharmaceuticals Inc | Goldberg Murray A | SVP Fin, Admin CFO Asst Secy | 1,850 | Option exercise at $20.32 | $37,592 | |
MDec 14 2012 | REGN | Regeneron Pharmaceuticals Inc | Yancopoulos George | EVP CSO Pres Regen Res Labs | 276,926 | Option payment at $179.13 | $49,605,754 | |
MDec 17 2012 | REGN | Regeneron Pharmaceuticals Inc | Yancopoulos George | EVP CSO Pres Regen Res Labs | 10,369 | Option exercise at $109.29 | $1,133,228 | |
Dec 14 2012 | REGN | Regeneron Pharmaceuticals Inc | Stahl Neil | SVP Res, Devel Sciences | 8,386 | Option payment at $179.13 | $1,502,184 | |
Dec 17 2012 | REGN | Regeneron Pharmaceuticals Inc | Stahl Neil | SVP Res, Devel Sciences | 5,952 | Option exercise at $16.80 | $99,994 | |
MDec 17 2012 | REGN | Regeneron Pharmaceuticals Inc | McCorkle Douglas S | VP Controller, Asst Treasurer | 5,000 | Option exercise at $16.80 | $84,000 | |
MDec 17 2012 | REGN | Regeneron Pharmaceuticals Inc | McCorkle Douglas S | VP Controller, Asst Treasurer | 1,000 | Sale at $179.20 | $179,198 | |
Dec 10 2012 | REGN | Regeneron Pharmaceuticals Inc | Aberman Michael S | VP Strategy, Investor Relat | 7,500 | Option exercise at $30.63 | $229,725 | |
MDec 10 2012 | REGN | Regeneron Pharmaceuticals Inc | Aberman Michael S | VP Strategy, Investor Relat | 4,132 | Option payment at $182.68 | $754,834 | |
MDec 11 2012 | REGN | Regeneron Pharmaceuticals Inc | Aberman Michael S | VP Strategy, Investor Relat | 3,368 | Sale at $185.06 | $623,268 | |
MNov 5 2012 | REGN | Regeneron Pharmaceuticals Inc | Roberts William | VP Regulat Dev, Med Safety | 94,947 | Gift at $0.00 | $0 | |
MNov 30 2012 | REGN | Regeneron Pharmaceuticals Inc | Roberts William | VP Regulat Dev, Med Safety | 11,500 | Sale at $180.78 | $2,078,975 | |
Nov 29 2012 | REGN | Regeneron Pharmaceuticals Inc | Aberman Michael S | VP Strategy, Investor Relat | 8,334 | Option exercise at $24.00 | $200,016 | |
MNov 29 2012 | REGN | Regeneron Pharmaceuticals Inc | Aberman Michael S | VP Strategy, Investor Relat | 4,430 | Option payment at $182.20 | $807,146 | |
MNov 30 2012 | REGN | Regeneron Pharmaceuticals Inc | Aberman Michael S | VP Strategy, Investor Relat | 3,904 | Sale at $180.64 | $705,228 | |
Nov 30 2012 | REGN | Regeneron Pharmaceuticals Inc | Stahl Neil | SVP Res, Devel Sciences | 17,182 | Sale at $181.01 | $3,110,114 | |
MNov 30 2012 | REGN | Regeneron Pharmaceuticals Inc | Stahl Neil | SVP Res, Devel Sciences | 9,483 | Option exercise at $21.09 | $199,994 | |
MNov 28 2012 | REGN | Regeneron Pharmaceuticals Inc | Vagelos P Roy | Chairman | 85,634 | Sale at $179.10 | $15,337,378 | |
Nov 29 2012 | REGN | Regeneron Pharmaceuticals Inc | Sing George L | Director | 5,000 | Sale at $185.00 | $925,000 | |
Nov 23 2012 | REGN | Regeneron Pharmaceuticals Inc | Vagelos P Roy | Chairman | 312,500 | Option exercise at $19.43 | $6,071,875 | |
MNov 23 2012 | REGN | Regeneron Pharmaceuticals Inc | Vagelos P Roy | Chairman | 162,113 | Option payment at $175.00 | $28,369,775 | |
MNov 26 2012 | REGN | Regeneron Pharmaceuticals Inc | Vagelos P Roy | Chairman | 64,753 | Sale at $175.22 | $11,345,934 | |
MNov 26 2012 | REGN | Regeneron Pharmaceuticals Inc | Baker Charles A | Director | 15,000 | Option exercise at $9.17 | $137,550 | |
MNov 26 2012 | REGN | Regeneron Pharmaceuticals Inc | Baker Charles A | Director | 15,000 | Sale at $173.87 | $2,607,986 | |
Nov 21 2012 | REGN | Regeneron Pharmaceuticals Inc | Terifay Robert J | SVP Commercial | 20,000 | Option exercise at $16.80 | $336,000 | |
MNov 21 2012 | REGN | Regeneron Pharmaceuticals Inc | Terifay Robert J | SVP Commercial | 10,255 | Option payment at $173.83 | $1,782,627 | |
MNov 23 2012 | REGN | Regeneron Pharmaceuticals Inc | Terifay Robert J | SVP Commercial | 9,745 | Sale at $174.44 | $1,699,970 | |
MNov 20 2012 | REGN | Regeneron Pharmaceuticals Inc | Stahl Neil | SVP Res, Devel Sciences | 54,500 | Option exercise at $16.80 | $915,600 | |
MNov 20 2012 | REGN | Regeneron Pharmaceuticals Inc | Stahl Neil | SVP Res, Devel Sciences | 30,143 | Option payment at $167.17 | $5,039,005 | |
MNov 21 2012 | REGN | Regeneron Pharmaceuticals Inc | Stahl Neil | SVP Res, Devel Sciences | 24,357 | Sale at $174.30 | $4,245,442 | |
Nov 16 2012 | REGN | Regeneron Pharmaceuticals Inc | Sing George L | Director | 5,000 | Sale at $152.00 | $760,000 |
M Multiple transactions summarized; earliest reported transaction date and average weighted transaction price
Yahoo Finance